Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorM.D. Anderson Cancer Center

About this trial

The purpose of this research study is to learn if a digital communication tool can improve how well patients with head and neck cancer and their caregivers understand the disease and treatment plan after their first consultation visit with the doctor/nurse practitioner.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults aged 18 to 100 years.

Diagnosed with head and neck cancer (all histologies included).

Receiving treatment for head and neck and prostate cancer at MDACC

Able to speak and understand English

Disqualifiers

Individuals without a diagnosis of head and neck cancer or prostate cancer.

Patients who do not speak English (since the digital tool is not translated).

Adults who are not caregivers of the eligible patient

Caregivers who do not speak English (tool not translated).

Trial design

Design model

Single group

Treatments tested in this trial

  • Survey

    Other intervention

    A 6-item structured questionnaire with Yes/No response options, followed by one open-ended free-text question.

Treatment groups

94 Participants
are divided into 1 treatment group
Group A: Patient/Caregiver: Use of MyCareGorithmExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Safety and Adverse Events (AEs)

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Time frame
Through study completion; an average of 1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: